Qiagen will acquire Spanish biotech STAT-Dx for up to €153M – more than 3 times the total funding it has raised so far – to produce fast and effective diagnostic tests for infections and cancer.
One Week Left to Apply!!
Deadline: Friday, February 9, 2018, 5pm
We are looking for the best university startups from schools around the world!
Over $1 million in Prizes! 42 startup teams will be invited to compete in front of hundreds of investors.
Join the more than 200 startups that have been successfully launched after competing at the RBPC and raised more than $1.7 billion!
Competition Dates: April 5-7, 2018
Rice University, HoustonJones Graduate School of Business
Global venture capital firm New Enterprise Associates, Inc. (NEA) today announced that Jeff Immelt has joined the firm as Venture Partner. Immelt, who recently retired from his role as Chairman and CEO of GE after 16 years at the helm of the 125-year-old company, is widely regarded as one of the world’s most innovative and capable business leaders. His extensive domain and company-building expertise are closely aligned with NEA’s core sectors of focus, and he will work closely with technology and healthcare companies across the firm’s portfolio in this new role.
A new oncology company spun out of Johns Hopkins School of Medicine is raising up to $40.5 million to develop its platform of anticancer therapies.
The U.Va. Licensing and Ventures group is offering funding to three local health and technology startups.
20/20 GeneSystems, Inc. finalized its first equity crowdfunding campaign this week with gross proceeds of $1.07 million, the maximum amount permitted under current SEC rules pursuant to Regulation CF. In so doing, the company became only the second medical technology firm to reach this maximum. 20/20 is now listed as one of the “Top 20 Regulation Crowdfunding Campaigns of All Time” by Crowdfund Capital Advisors. The campaign was posted on First Democracy VC, a joint venture between Indiegogo and MicroVentures and was assisted by marketing firm Enventys Partners.
Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid tumors.
Betamore, Johns Hopkins Technology Ventures and the University of Maryland, Baltimore are looking for five local digital health, bio-health or life sciences companies to participate in a new collaborative accelerator program.
A new study from the Karolinska Institutet in Stockholm, Sweden, suggests that replacing time spent sitting with light-intensity physical activity may benefit health more than previously thought.
March 22, 2018 5:30 – 8:00 p.m.
The Grand Lodge of Maryland 304 International Cir Cockeysville, MD 21030
Influential Marylanders was created to honor individuals who have made significant impacts in their field and continue to be leaders in Maryland. These individuals are selected by The Daily Record’s editors for their significant contributions to their respective fields and for their leadership in Maryland in the following areas: civic leadership; communications; education; finance; freestyle; general business; health care; law; philanthropy; real estate; and technology. Three-time winners are inducted into the Circle of Influence.